research peptide FAQ

Switch to the opposite nostril or delay administration until nasal passages clear. Semax absorption occurs in the olfactory epithelium high in the nasal cavity. Not the lower turbinates where most congestion occurs. Tilting the head back 45 degrees during administration directs the spray toward the olfactory region rather than draining into the throat. If congestion persists, a saline rinse 10 minutes before semax administration can temporarily clear mucus without affecting peptide absorption. Avoid using decongestant sprays (oxymetazoline, phenylephrine) immediately before semax. Vasoconstriction reduces blood flow to nasal mucosa and may impair peptide uptake.

Do not use the peptide. A +1.2 Da error suggests either an amino acid substitution or incomplete reduction of a disulphide bond. Contact the supplier for a corrected synthesis or request mass spec/MS analysis to identify the modification. Without fragmentation data, you can't confirm the peptide's sequence integrity.

Request the full HPLC chromatogram and examine the minor peak pattern. If multiple minor peaks appear at retention times close to the main peak, deletion sequences or incomplete deprotection products are present. These can compete for receptor binding or alter pharmacokinetics without dramatically affecting purity percentage. A peptide with 96% purity from one dominant impurity behaves more predictably than 96% purity from six different impurities at 0.5–1% each. If the vendor can't provide chromatogram images, assume quality documentation is incomplete and source from a supplier that performs full vip comparative studies on every batch.

If the lyophilised vial feels warm to the touch upon delivery, check the shipping timeline. Lyophilised peptides can tolerate ambient temperature (15–25°C) for 48–72 hours without significant degradation. The absence of water in the lyophilised state prevents hydrolytic breakdown even at room temperature. If shipping took longer than 72 hours, contact the supplier for a replacement. At Real Peptides, we ship with cold packs for this exact reason, but delays beyond carrier control do happen.

That's acceptable for lyophilised storage but not ideal. Minor fluctuations within the subzero range don't introduce enough thermal energy to denature the peptide in its freeze-dried state. The bigger risk is condensation. If the vial warms enough for moisture to condense on the stopper, that water vapor can rehydrate the powder. Store the vial in a sealed plastic bag to create a moisture barrier, and check the powder visually before reconstitution. If it looks clumpy or discolored instead of fine and white, moisture has infiltrated.

Multiple mass spec peaks indicate a heterogeneous sample. Typically deletion sequences, truncation products, or oxidation variants. The dominant peak should match your target peptide's calculated mass; secondary peaks 14–16 Da higher suggest methionine oxidation (common during synthesis), while peaks 1–2 amino acid masses lower indicate deletion sequences. If secondary peaks represent more than 5% of total ion current, the peptide doesn't meet research-grade standards. For critical experiments, request re-synthesis or switch suppliers rather than attempting to use a chemically impure preparation.

Use a portable medical cooler designed for insulin or peptide transport. Brands like FRIO or MedActiv maintain 2–8°C for 24–48 hours using evaporative cooling without requiring ice or refrigeration. Pack the vial upright, cushioned to prevent physical agitation during transport. Avoid gel ice packs placed directly against the vial. They can freeze the solution if they're too cold. If transport time exceeds 48 hours, reconstitute a fresh vial at the destination site rather than risking temperature excursions mid-transit.

Check the actual temperature the vials reached using a freezer thermometer if available. If the internal temperature stayed below 0°C, the lyophilised peptide is fine. No action needed. If it rose above 0°C but stayed below 15°C for fewer than 12 hours, expect minor potency loss (5–10%) but the vial remains usable. If the temperature exceeded 15°C or stayed warm for more than 24 hours, treat this as a compromised batch. The peptide won't look different, but the tertiary structure may have partially unfolded, reducing receptor-binding efficacy.

Split the lyophilised powder into smaller aliquots before the 24-month mark. Reconstitute one aliquot at a time so you're not repeatedly thawing and refreezing a single large batch. Each freeze-thaw cycle introduces moisture and accelerates degradation. If you must store beyond two years, keep the vial at −80°C (ultralow freezer) instead of −20°C. Peptide stability extends to 36–48 months at ultralow temperatures, though few labs have routine access to −80°C storage.

Discard the vial and start fresh. A reconstituted peptide left at room temperature (20–25°C) for 8–12 hours has likely lost 30–50% of its potency through accelerated hydrolysis and thermal denaturation. You can't visually confirm potency loss. The solution will still look clear and normal. But the biological activity is compromised. The cost of replacing the vial is far lower than the risk of using a degraded compound in research where dose accuracy matters.

Run side-by-side receptor binding assays or functional assays using identical protocols and fresh reconstitutions from both suppliers. Differences in EC50 values greater than 2-fold suggest purity or potency differences the COAs didn't capture. If both peptides show similar activity but one costs significantly less, examine the minor peak profiles in their HPLC traces. Cheaper synthesis often tolerates higher impurity levels that don't affect simple binding assays but may confound long-term stability studies. Our team routinely tests samples from multiple batches before committing to large-volume orders; the upfront cost of comparative testing is negligible compared to months of compromised experimental data.

Discard it. Semax amidate undergoes hydrolytic cleavage at the Met-Glu bond when stored above 8°C, and the degradation is time-dependent. 24 hours at 20–25°C results in approximately 30% potency loss, while 48 hours can exceed 50% loss. The peptide may still appear clear and unchanged, but receptor binding affinity drops substantially. There is no reliable way to test potency at home. If the cold chain was broken for more than 12 hours, the research batch is compromised.

Verify batch consistency first. Run HPLC on samples from different vials within the same lot. Inconsistent purity across vials within a single batch indicates synthesis process variability or improper lyophilization. If within-batch purity varies by more than 2%, the issue is manufacturing control. If purity is consistent but results still don't replicate, the next variable is reconstitution protocol. Peptides reconstituted in incorrect solvents or at wrong pH can form aggregates that alter bioavailability without changing visual appearance.

Request them before placing another order. A legitimate supplier provides HPLC and mass spectrometry data as standard documentation, not premium add-ons. If they cite 'proprietary methods' or 'internal testing only', that's a verification gap you can't audit. The alternative: source from a supplier who includes third-party test results with every shipment. For peptide-based studies heading to publication, reviewers will request this data during manuscript review. Securing it upfront prevents re-running experiments with properly documented compounds later.

Contact the supplier immediately and request re-testing before reconstituting the peptide. Lyophilized peptides that experienced heat exposure may appear visually identical but have undergone partial denaturation. The only reliable confirmation is re-running HPLC to compare current purity against the original Certificate of Analysis. Most research-grade suppliers include time-temperature indicators in shipments precisely to catch this. If yours doesn't, request it as standard for future orders.

Discard it. Reconstituted dihexa left at room temperature for more than 2 hours has undergone measurable aggregation and oxidative degradation. The solution may still look clear and sterile, but peptide bioactivity has dropped significantly. There's no home test to confirm potency. And using degraded peptide in a research protocol introduces confounding variables that invalidate your results. The cost of replacing one vial is negligible compared to the cost of unreliable data across an entire study.

Assess whether the vial seal remained intact and whether ambient humidity exceeded 60%. If both conditions held. Sealed vial, dry environment. The peptide likely retained 85–90% potency, though some aggregation may have started. Refrigerate or freeze it immediately and use it within the next 30 days rather than storing it for the full 24-month window. If the seal was compromised or the environment was humid, the powder may have absorbed moisture, which accelerates degradation even after you return it to freezer storage. Consider this batch compromised for long-term studies where precision dosing matters.

Aliquot the unused solution into sterile single-use volumes (0.5–1.0 mL cryovials), label them with the reconstitution date, and freeze at −20°C immediately. Don't wait until day 27 to freeze leftovers. This extends usability to 3–6 months, but you'll accept 10–15% activity loss from the freeze-thaw process. Thaw one vial at a time in the refrigerator when needed and use it within 24 hours of thawing. Do not refreeze thawed aliquots. Discard any unused solution after 24 hours post-thaw.

Check reconstitution technique and storage conditions first. Inconsistent dosing is the most common variable. Nasal spray devices deliver 50–100 µL per actuation, but this depends on the spray being primed correctly and held upright during administration. If the device wasn't primed before the first use, the first 2–3 actuations may deliver saline or air rather than peptide solution. Freeze-thaw cycles or exposure to light also degrade semax unpredictably. Store reconstituted vials in amber glass and keep them refrigerated between uses. If storage and technique are controlled but results still vary, peptide purity is the next variable to investigate.

'ND' (Not Detected) without a stated detection limit is unacceptable. It could mean <0.001 EU/mg or <10 EU/mg depending on assay sensitivity. Request a quantitative LAL result with the detection limit explicitly stated. For in vivo studies or primary immune cell work, insist on <0.1 EU/mg confirmed via LAL Kinetic Chromogenic method.